| __timestamp | PTC Therapeutics, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 2917513 |
| Thursday, January 1, 2015 | 82080000 | 7878291 |
| Friday, January 1, 2016 | 97130000 | 8366794 |
| Sunday, January 1, 2017 | 121271000 | 6610381 |
| Monday, January 1, 2018 | 153548000 | 6556000 |
| Tuesday, January 1, 2019 | 202541000 | 6930000 |
| Wednesday, January 1, 2020 | 245164000 | 8758000 |
| Friday, January 1, 2021 | 285773000 | 10806000 |
| Saturday, January 1, 2022 | 325998000 | 9844000 |
| Sunday, January 1, 2023 | 332540000 | 13481000 |
Data in motion
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. From 2014 to 2023, PTC Therapeutics, Inc. and Soleno Therapeutics, Inc. have shown contrasting approaches. PTC Therapeutics has seen a significant rise in SG&A expenses, increasing by over 640% from 2014 to 2023. In contrast, Soleno Therapeutics has maintained a more stable trajectory, with expenses growing by approximately 360% over the same period.
This data suggests that while PTC Therapeutics is expanding its operations, it may also be facing challenges in controlling costs. Meanwhile, Soleno Therapeutics appears to be more conservative in its spending, potentially indicating a more controlled growth strategy. Investors and stakeholders should consider these trends when evaluating the financial strategies of these companies.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Zoetis Inc. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or PTC Therapeutics, Inc.
Breaking Down SG&A Expenses: Viatris Inc. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Soleno Therapeutics, Inc. Trends and Insights
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared